Allscripts purchased a 10% stake in the cloud-based healthcare IT company, following on from a strategic partnership formed by the two in March this year.
NantHealth, a healthcare IT subsidiary of US-based computing technology conglomerate NantWorks, secured $200m in equity funding from healthcare IT services provider Allscripts yesterday in return for a 10% stake.
NantHealth is developing a molecular diagnostic test for personalised cancer treatments. The data gained from the test is then fed into a platform that enables medical professionals to access clinical trials, track a patient’s progress and monitor costs in real-time.
Allscripts and NantHealth initially signed a collaboration agreement in March this…
